Nuvectis Pharma, Inc.
We are a biopharmaceutical company focused on the development of innovative precision medicines for the treatment of serious unmet medical needs in oncology. We are currently developing two preclinical drug candidates with the lead candidate expected to begin a Phase 1 clinical trial in the fourth quarter of 2021. NXP800, one of our lead preclinical drug […]
November 17, 2021 Read More